Real‐world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single‐centre, prospective 1‐year observational cohort study of the first 100 patients treated-Reference-Cited by-同舟云学术

Real‐world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single‐centre, prospective 1‐year observational cohort study of the first 100 patients treated

Published:2021-02-28 Issue:4 Volume:184 Page:755-757
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Sears A.V.¹^ORCID,Woolf R.T.¹^ORCID,Gribaleva E.¹²,Abdelrahman W.¹,Robbie S.³,Menon B.⁴,Kirkham B.⁴,Smith C.H.¹⁵^ORCID,Pink A.E.¹^ORCID

Affiliation:

1. St John’s Institute of DermatologyGuy’s and St Thomas’ NHS Foundation Trust London UK

2. I.M. Sechenov First Moscow State Medical University (Sechenov University) Moscow Russian Federation

3. Department of Ophthalmology Guy’s and St Thomas’ NHS Foundation Trust London UK

4. Department of Rheumatology Guy’s and St Thomas’ NHS Foundation Trust London UK

5. St John’s Institute of DermatologySchool of Basic and Medical Biosciences, Faculty of Life Sciences and MedicineKing’s College London London UK

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19631

Reference8 articles.

1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

2. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

3. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

4. Medical Dictionary for Regulatory Activities. Available at:https://www.meddra.org/(last accessed 8 January 2020).

5. Clearance of molluscum contagiosum virus infection in patients with atopic eczema treated with dupilumab

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically Proxied Interleukin‐13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study;Arthritis & Rheumatology;2024-07-31

2. Dupilumab and joint‐related adverse effects: A systematic review;Journal of the European Academy of Dermatology and Venereology;2024-07-02

3. Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options;Journal of Investigative Dermatology;2024-07

4. Immune-Targeted Therapies for Depression;The Journal of Clinical Psychiatry;2024-06-24

5. A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbidities;JAAD International;2024-06